United States Venous Stents Market 2033 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

The Global Venous Stents Market reached US$ 1.24 billion in 2024 and is expected to reach US$ 2.62 billion by 2033, growing at a CAGR of 8.5% during the forecast period 2025-2033.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/venous-stents-market?sb

Key Development:

United States: Recent Venous Stent Developments

✅ In November 2025, W. L. Gore & Associates reported that the investigational GORE® VIABAHN® FORTEGRA Venous Stent met its primary endpoint in a deep venous iliocaval obstruction clinical trial, showing strong 12‐month patency and safety outcomes in complex venous disease.

✅ In November 2025, results presented at The VEINS 2025 conference highlighted that the VIABAHN FORTEGRA trial demonstrated high vessel‐specific primary patency rates in IVC and iliofemoral regions with no migrations, fractures, or major safety events through 12 months.

✅ In August 2025, Venous Stent B.V. completed a convertible‐note funding round with strong investor support to advance its next‐generation iliac venous stent technology toward pre‐clinical and first‐in‐human trials.

✅ In August 2025, Venous Stent's leadership participated in key interventional radiology events (CIRSE 2025, LSI Europe London) to showcase its innovative venous stent platform and build collaborations ahead of clinical development.

Japan: Recent Venous Stent Developments

✅ In October 2025, the Japanese Society of Phlebology updated clinical guidelines to recommend stenting for May‐Thurner Syndrome, clarifying indications for venous stents versus conservative therapy and standardizing treatment of iliac vein compression in Japan.

✅ In September 2025, Boston Scientific Japan received approval for a specialized delivery system for its venous stent, enabling more precise placement in tortuous veins and improving procedural success rates in Japanese hospitals.

✅ In August 2025, at the 20th Japan Endovascular Symposium, sessions highlighted VENOVOTM Venous Stent System as Japan's first dedicated iliac venous stent, discussing patient selection and procedural insights for clinical practice.

✅ In July 2025, a Japanese university hospital published long‐term patency research on venous stents in Asian patients, suggesting slight differences in healing response compared to Western populations and contributing to localized clinical evidence for venous treatment in Japan.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=venous-stents-market

Europe: Recent Venous Stent Developments

✅ In November 2025, clinical data from Gore's VIABAHN FORTEGRA trial were presented internationally, underscoring the growing evidence base for complex venous stent use across iliofemoral and IVC regions relevant to European practice.

✅ In November 2025, the demonstration of positive clinical outcomes from investigational venous stent research at major vascular conferences reinforced Europe's role in advancing evidence for venous intervention strategies.

✅ In August 2025, Venous Stent B.V. showcased its iliac venous stent platform at CIRSE 2025 in Barcelona engaging European interventional radiologists and highlighting progress toward clinical milestones.

✅ In August 2025, Venous Stent's participation at LSI Europe in London provided exposure among medtech innovators and potential partners as the company advances its next‐gen venous stent toward trials.

Key Players:

=> Medtronic Plc, Boston Scientific Corporation, Cook Medical, Terumo Corporation, Becton, Dickinson and Company (BD), Abbott Laboratories, Cordis Corporation(Cardinal Health), Vesper Medical, Bentley, Optimed Medizinische Instrumente GmbH and among others.

Key Segments:

By Product Type

Covered Stents dominate the market, providing targeted therapy for vascular occlusions and reducing restenosis risk.
Self-Expanding Stents are widely used in dynamic vessels requiring flexibility and continuous radial force.
Balloon-Expandable Stents are preferred for precision placement in coronary and peripheral interventions.
Bare Stents continue to hold a presence in cost-sensitive markets and specific clinical indications.

By Material

Nitinol leads due to its excellent shape memory and superelastic properties, ideal for self-expanding stents.
Metal Stents are widely adopted for their mechanical strength and reliability.
Stainless Steel remains a standard choice in coronary and peripheral vascular interventions.
Polymers are gaining traction in bioresorbable stent applications.
Others include cobalt-chromium and titanium alloys for specialized clinical needs.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/venous-stents-market?sb

By Application

Deep Vein Thrombosis (DVT) drives adoption due to increasing prevalence of venous thromboembolism.
Chronic Venous Insufficiency (CVI) is a significant application, especially in aging populations.
Pulmonary Embolism (PE) interventions are growing, aided by minimally invasive stent procedures.
Tumor Occlusion represents a niche but high-value segment in oncology vascular interventions.
Others include vascular anomalies, aneurysms, and peripheral artery disease treatments.

By Distribution Channel

Hospitals hold the largest share, as they are primary centers for interventional cardiology and vascular procedures.
Specialty Clinics contribute significantly due to focused vascular and interventional services.
Ambulatory Surgical Centers (ASCs) are increasingly preferred for minimally invasive stent procedures, supporting outpatient care.

By Region

North America - 35% Share
Market growth is driven by advanced healthcare infrastructure, rising prevalence of cardiovascular diseases, and high adoption of innovative stents.

Europe - 28% Share
Growth supported by established healthcare systems, reimbursement frameworks, and minimally invasive procedure adoption.

Asia-Pacific - 25% Share
Rapid growth due to increasing healthcare access, rising cardiovascular disease burden, and expanding interventional cardiology centers.

South America - 7% Share
Growth fueled by improving healthcare infrastructure and awareness of vascular disease interventions.

Middle East & Africa - 5% Share
Emerging markets with growing healthcare investments and increasing adoption of minimally invasive vascular treatments.

FAQ

What is the current size of the Venous Stents Market?

A: In 2024, the Venous Stents Market was valued at US$ 1.24 billion, reflecting its strong industry presence.

Q2: How large is the Venous Stents Market expected to be by 2033?

A: By 2033, industry forecasts suggest the Venous Stents Market will grow to around US$ 2.62 billion, demonstrating significant expansion.

Q3: What is the growth rate of the Venous Stents Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 8.5% during the forecast period from 2025 to 2033.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.